Literature DB >> 12010882

Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells.

V Liévin-Le Moal1, R Amsellem, A L Servin, M-H Coconnier.   

Abstract

BACKGROUND AND AIMS: The normal gastrointestinal microflora exerts a barrier effect against enteropathogens. The aim of this study was to examine whether lactobacilli, a minor genus of the resident gut microflora, exerts a protective effect against the cellular injuries promoted by the diarrhoeagenic Afa/Dr diffusely adhering Escherichia coli (Afa/Dr DAEC) C1845 strain in human intestinal cells.
METHODS: Cultured human intestinal fully differentiated enterocyte-like Caco-2/TC7 cells were used. Antibacterial activity was examined by measuring the viability of the adhering C1845 bacteria. The distribution of brush border associated cytoskeleton and functional proteins was examined by immunofluorescence labelling coupled to confocal laser scanning microscopy analysis.
RESULTS: The activity of Lactobacillus acidophilus strain LB isolated from the resident human gastrointestinal microflora was examined. A dose dependent decrease in viability of C1845 bacteria was observed after both direct contact in vitro between the spent culture supernatant (LB-SCS) and the bacteria, and when the bacteria were adherent on Caco-2/TC7 cells. Protection against the C1845 induced alterations in expression of F-actin, sucrase-isomaltase, dipeptidylpeptidase IV, alkaline phosphatase, and fructose transporter alterations was observed when the cells were exposed to LB-SCS.
CONCLUSION: L acidophilus strain isolated from the resident adult human gastrointestinal microflora, together with its antimicrobial activity, exerts a protective effect against the brush border lesions promoted by the diarrhoeagenic Afa/Dr DAEC strain C1845.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010882      PMCID: PMC1773224          DOI: 10.1136/gut.50.6.803

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  47 in total

Review 1.  Enteropathies associated with protracted diarrhea of infancy: clinicopathological features, cellular and molecular mechanisms.

Authors:  E Cutz; P M Sherman; G P Davidson
Journal:  Pediatr Pathol Lab Med       Date:  1997 May-Jun

2.  Effect of erythromycin on Shigella infection of Caco-2 cells.

Authors:  Y Honma; C Sasakawa; T Tsuji; M Iwanaga
Journal:  FEMS Immunol Med Microbiol       Date:  2000-02

3.  Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.

Authors:  P C Braga; M D Sasso; M T Sala
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

4.  Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Liévin; M F Bernet-Camard; S Hudault; A L Servin
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Rotavirus infection induces an increase in intracellular calcium concentration in human intestinal epithelial cells: role in microvillar actin alteration.

Authors:  J P Brunet; J Cotte-Laffitte; C Linxe; A M Quero; M Géniteau-Legendre; A Servin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells.

Authors:  M F Bernet-Camard; M H Coconnier; S Hudault; A L Servin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 7.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection.

Authors:  S Hudault; V Liévin; M F Bernet-Camard; A L Servin
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

9.  Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells.

Authors:  M H Coconnier; V Liévin; M Lorrot; A L Servin
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

10.  In vivo, villin is required for Ca(2+)-dependent F-actin disruption in intestinal brush borders.

Authors:  E Ferrary; M Cohen-Tannoudji; G Pehau-Arnaudet; A Lapillonne; R Athman; T Ruiz; L Boulouha; F El Marjou; A Doye; J J Fontaine; C Antony; C Babinet; D Louvard; F Jaisser; S Robine
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

View more
  39 in total

Review 1.  Probiotics for infectious diarrhoea.

Authors:  E Isolauri
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 2.  Relationship between intestinal microbiota and colorectal cancer.

Authors:  Gokhan Cipe; Ufuk Oguz Idiz; Deniz Firat; Huseyin Bektasoglu
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence?

Authors:  Luis Vitetta
Journal:  Dig Dis Sci       Date:  2016-06       Impact factor: 3.199

4.  Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.

Authors:  Philip M Sherman; Kathene C Johnson-Henry; Helen P Yeung; Peter S C Ngo; Jacques Goulet; Thomas A Tompkins
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 5.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 6.  The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.

Authors:  Julia B Ewaschuk; Qassim Z Tejpar; Isaac Soo; Karen Madsen; Richard N Fedorak
Journal:  Curr Gastroenterol Rep       Date:  2006-12

7.  A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.

Authors:  Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

Review 8.  Protective role of gut commensal microbes against intestinal infections.

Authors:  Mi Young Yoon; My Young Yoon; Keehoon Lee; Sang Sun Yoon
Journal:  J Microbiol       Date:  2014-11-29       Impact factor: 3.422

Review 9.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

10.  Probiotics affect virulence-related gene expression in Escherichia coli O157:H7.

Authors:  Maira Jessica Medellin-Peña; Haifeng Wang; Roger Johnson; Sanjeev Anand; Mansel W Griffiths
Journal:  Appl Environ Microbiol       Date:  2007-05-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.